Latest filing published 28 Oct 2015 for HAEMONETICS CORP, €9,300.
Insider track record
No signal scores available.
Closed purchases
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +8.6%Entry US$35.72 · Close at T+365 US$38.81
- +6.2%Entry US$33.63 · Close at T+365 US$35.72
- -0.7%Entry US$29.39 · Close at T+365 US$29.17
- +19.6%Entry US$28.11 · Close at T+365 US$33.63
- +4.8%Entry US$27.63 · Close at T+365 US$28.95
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jonathan White: trading record in brief
Jonathan White discloses dealings in Haemonetics Corp to SEC (Form 4). In total, 38 filings cover trades dated from 28 January 2009 to 26 October 2015.
In open-market terms, that means 7 purchases worth €139k on one side and 7 sales worth €252k on the other. On balance, insiders were net sellers of €112k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 11 share grants. 2015 to date brings no purchases and 3 sales.
Half of the purchases are above €15k and half below. Looking at 6 purchases old enough to measure, the stock rose over the following 90 days in 33% of cases; the median change was -1.6%. They describe history only and say nothing certain about the share price ahead.
On 28 October 2015 came the latest disclosure, an open-market sale for €9,300 in Haemonetics Corp. The last insider purchase was made public on 2 May 2013, 4,939 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jonathan White
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 319 shares@ US$32.13Common StockSEC:0001127602-15-029706:0
- 4,105 shares@ US$0.01Common StockSEC:0001127602-15-029493:0
- 602 shares@ US$39.15Common StockSEC:0000313143-15-000051:0
- 2,385 shares@ US$41.14Common StockSEC:0000313143-15-000046:0
- 316 shares@ US$36.22Common StockSEC:0000313143-14-000123:1
- 3,057 shares0Common StockSEC:0000313143-14-000112:0
- 210 shares@ US$35.44Common StockSEC:0000313143-14-000112:1
- 719 shares@ US$35.29Common StockSEC:0000313143-14-000072:0
- 700 shares@ US$38.66Common StockSEC:0000313143-14-000024:0
- 315 shares@ US$38.67Common StockSEC:0000313143-14-000024:1
- 865 shares@ US$38.66Common StockSEC:0000313143-14-000024:2
- 329 shares@ US$39.55Common StockSEC:0000313143-13-000183:0
- 298 shares@ US$39.55Common StockSEC:0000313143-13-000183:1
- 129 shares@ US$39.55Common StockSEC:0000313143-13-000183:2
- 3,060 shares0Common StockSEC:0000313143-13-000172:0
- 3,060 shares0Common StockSEC:0000313143-13-000173:0
- 600 shares@ US$45.66Common StockSEC:0000313143-13-000104:0
- 3,000 shares@ US$40.69Common StockSEC:0000313143-13-000036:0
- 211 shares@ US$44.01Common StockSEC:0000313143-13-000020:0
- 145 shares@ US$76.33Common StockSEC:0000313143-12-000209:0
- 63 shares@ US$76.33Common StockSEC:0000313143-12-000209:1
- 157 shares@ US$78.51Common StockSEC:0000313143-12-000195:0
- 1,728 shares0Common StockSEC:0000313143-12-000180:0
- 426 shares@ US$49.83Common StockSEC:0000313143-12-000047:0Canonical exit: 30 Jul 2012 (T+90)
- 1,956 shares@ US$0.01Common StockSEC:0000313143-11-000111:0
25 of 33 declarations
